After-Hours Stock Movers:
Cerecor Inc. (NASDAQ: CERC) 14.4% HIGHER; announced positive initial results from a Phase 1b proof-of-concept study evaluating CERC-002, an investigational first-in-class fully human anti-LIGHT (tumor necrosis factor superfamily member 14 (TNFSF14)) monoclonal antibody, in adult patients with moderate to severe Crohn's disease (CD). Crohn’s disease is a disorder affecting as many as 780,000 people in the United States.
Big Digital, Inc. (NASDAQ: BTBT) 13.3% LOWER; gained 110% intra-day on move higher in bitcoin. Bitcoin reversed late in the day on reports Amazon will not accept bitcoin this year.
Minim Inc. (NASDAQ: MINM) 6.9% LOWER; announced the launch of the Company's proposed public offering of $25 million pursuant to a registration statement filed with the Securities and Exchange Commission (SEC).
Universal Health (NYSE: UHS) 6.7% HIGHER; reported Q2 EPS of $3.76, $1.08 better than the analyst estimate of $2.68. Revenue for the quarter came in at $3.2 billion versus the consensus estimate of $3.01 billion. Announces $1 Billion Increase To Stock Repurchase Program Authorization
F5 Networks (NASDAQ: FFIV) 5.9% HIGHER; reported Q3 EPS of $2.76, $0.30 better than the analyst estimate of $2.46. Revenue for the quarter came in at $652 million versus the consensus estimate of $638.14 million. F5 Networks sees Q4 2021 EPS of $2.68-$2.80, versus the consensus of $2.71. F5 Networks sees Q4 2021 revenue of $660-680 million, versus the consensus of $662.1 million.
ThredUp Inc. (Nasdaq: TDUP) 5% LOWER; announced today the launch of the public offering of 6,424,369 shares of its Class A common stock, consisting of 2,000,000 shares to be issued and sold by thredUP and 4,424,369 shares to be sold by existing stockholders of thredUP
Trinet (NYSE: TNET) 4.5% HIGHER; reported Q2 EPS of $1.56, $0.75 better than the analyst estimate of $0.81. Revenue for the quarter came in at $1.1 million versus the consensus estimate of $236.27 million.
Amkor Technology (NASDAQ: AMKR) 4% HIGHER; reported Q2 EPS of $0.51, $0.04 better than the analyst estimate of $0.47. Revenue for the quarter came in at $1.41 billion versus the consensus estimate of $1.35 billion. Amkor Technology sees Q3 2021 EPS of $0.60-$0.80, versus the consensus of $0.44. Amkor Technology sees Q3 2021 revenue of $1.65-1.75 billion, versus the consensus of $1.51 billion.
Independence (NYSE: IRT) 5.3% LOWER; commencing an underwritten public offering of 14,000,000 shares of common stock.
精彩评论